Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study

NCT02780089 · clinicaltrials.gov ↗
COMPLETED
Status
408
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bristol-Myers Squibb